Table 2.
Demographic and clinical data of the study groups
| Variable | Cirrhotic/HCC | Chronic active | Inactive carrier | P-value | |
|---|---|---|---|---|---|
| No. of patients | 26 | 20 | 27 | – | |
| Gender, n (%) | |||||
| Male | 23 (88.5) | 15 (75) | 17 (63) | 0.72 | |
| Female | 3 (11.5) | 5 (25) | 10 (37) | ||
| Mean age ±SD | 50.9 ±11.8 | 40.7 ±14.2 | 49.2 ±12.9 | 0.094 | |
| ALT ±SD | 48.8 ±27.7 | 40.3±24 | 21.5 ±9.6 | < 0.001 | |
| AST ±SD | 76.0 ±50.2 | 34±12.3 | 21.9 ±4.7 | < 0.001 | |
| HBeAg positive, n (%) | 3/26 (11.5) | 7/20 (35) | 0/27 (0) | < 0.01 | |
| HBeAb, n (%) | 23/26 (88.46) | 13/20 (65) | 27/27 (100) | 0.62 | |
| HBsAg positive, n (%) | 26/26 (100) | 20/20 (100) | 27/27 (100) | – | |
ALT – alanine aminotransferase, AST – aspartate aminotransferase, SD – standard deviation